Press releases from University of Oxford or clinical trial registries

Oxford Scientists in UK Develop World's First Ovarian Cancer Vaccine, OvarianVax

Oct 4, 2024, 07:03 AM

Scientists at the University of Oxford in the UK have developed the world's first ovarian cancer vaccine, named OvarianVax, which could potentially eliminate the disease. The vaccine works by teaching the immune system to recognize and attack the earliest stages of ovarian cancer. Professor Ahmed Ahmed, who leads the research team, has expressed hope that this breakthrough could significantly impact the fight against one of the deadliest cancers affecting women globally. Researchers aim to have the vaccine available to patients by the end of the decade.